Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IM Cannabis Corp. (IMCC) vs PainReform Ltd. (PRFX)

IM Cannabis Corp. and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $3.0M against $2.0M — 1.5× the size. PainReform Ltd. has the higher net margin (0.00% vs −38.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, IM Cannabis Corp. leads on 6 and PainReform Ltd. on 6.

Valuation

Metric IMCC PRFX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.03 n/m 2.25
P/B n/m 0.00 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.99 12.29
EV/Sales 0.02 n/m 2.56
Earnings yield (2,710.65%) (61,696.04%) (2.99%)
Free cash flow yield (55.53%) (80,633.63%) 0.00%

Profitability

Metric IMCC PRFX Drug Manufacturers Specialty & Generic median
Gross margin 12.62% 0.00% 53.94%
Operating margin (32.88%) 0.00% 0.00%
Net margin (38.92%) 0.00% 0.00%
Free cash flow margin (1.47%) 0.00% 0.00%
Return on equity 2,280.06% 0.00% (0.40%)
Return on assets (54.20%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMCC PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (11.97%) — 10.01%
EPS growth (last fiscal year) 41.95% 92.92% —
Revenue growth, 5-year CAGR 26.99% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMCC PRFX Drug Manufacturers Specialty & Generic median
Debt to equity (0.12) 0.00 0.05
Current ratio 0.56 5.07 2.31
Net debt to EBITDA 0.18 0.96 0.85

Dividend

Metric IMCC PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric IMCC PRFX Drug Manufacturers Specialty & Generic median
Market cap 1.95m 2.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack